Matches in SemOpenAlex for { <https://semopenalex.org/work/W2033996003> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2033996003 endingPage "144" @default.
- W2033996003 startingPage "139" @default.
- W2033996003 abstract "A 74 year-old Japanese woman, who had suffered from Lambert-Eaton myasthenic syndrome (LEMS), Sjoegren's syndrome, and discoid lupus erythematosus for 10 years and had been successfully controlled by 3,4-diaminopyridine and prednisolone, began to suffer from chest discomfort at night. Stress-induced myocardial ischemia in the left ventricular anterior septum was detected by thallium-201 scintigraphy. After diltiazem was prescribed, she began to feel systemic malaise and weakness in both thighs. She stopped taking diltiazem and the symptoms improved. Coronary angiography revealed 75% stenosis with calcification in the middle of the left anterior descending artery. After atherectomy with a lotablator and coronary stenting, diltiazem was prescribed. She felt malaise again, but continued taking diltiazem. After three months a follow-up coronary angiography showed no restenosis in the lesion and diltiazem was stopped. The weakness and malaise disappeared and her muscle strength recovered. LEMS is an autoimmune disorder of peripheral cholinergic transmission in which autoantibodies to the presynaptic P/Q-type voltage-gated calcium channels (VGCC) decrease the release of acetylcholine at the neuromuscular junction resulting in muscle weakness. P/Q-type VGCC regulates most of the neurotransmitter release and L-type VGCC regulates the remainder. L-type VGCC blockers are thought to have little effect on the neuromuscular junction. but they should be used very carefully. even in the remission stage of LEMS, because of preexisting neuromuscular blocking in transmission." @default.
- W2033996003 created "2016-06-24" @default.
- W2033996003 creator A5000377104 @default.
- W2033996003 creator A5010778291 @default.
- W2033996003 creator A5023817300 @default.
- W2033996003 creator A5031290868 @default.
- W2033996003 creator A5032400721 @default.
- W2033996003 creator A5033371779 @default.
- W2033996003 creator A5035729104 @default.
- W2033996003 creator A5063080687 @default.
- W2033996003 creator A5079883757 @default.
- W2033996003 date "2003-01-01" @default.
- W2033996003 modified "2023-10-16" @default.
- W2033996003 title "Exacerbation of Lambert-Eaton Myasthenic Syndrome Caused by an L-type Ca2+Channel Antagonist." @default.
- W2033996003 cites W1965913937 @default.
- W2033996003 cites W1974623748 @default.
- W2033996003 cites W1987212226 @default.
- W2033996003 cites W1993472268 @default.
- W2033996003 cites W2005175773 @default.
- W2033996003 cites W2063029006 @default.
- W2033996003 cites W2069798727 @default.
- W2033996003 cites W2070988327 @default.
- W2033996003 cites W2077981014 @default.
- W2033996003 cites W2149340564 @default.
- W2033996003 cites W2165328940 @default.
- W2033996003 doi "https://doi.org/10.1536/jhj.44.139" @default.
- W2033996003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12622445" @default.
- W2033996003 hasPublicationYear "2003" @default.
- W2033996003 type Work @default.
- W2033996003 sameAs 2033996003 @default.
- W2033996003 citedByCount "8" @default.
- W2033996003 countsByYear W20339960032018 @default.
- W2033996003 countsByYear W20339960032021 @default.
- W2033996003 countsByYear W20339960032023 @default.
- W2033996003 crossrefType "journal-article" @default.
- W2033996003 hasAuthorship W2033996003A5000377104 @default.
- W2033996003 hasAuthorship W2033996003A5010778291 @default.
- W2033996003 hasAuthorship W2033996003A5023817300 @default.
- W2033996003 hasAuthorship W2033996003A5031290868 @default.
- W2033996003 hasAuthorship W2033996003A5032400721 @default.
- W2033996003 hasAuthorship W2033996003A5033371779 @default.
- W2033996003 hasAuthorship W2033996003A5035729104 @default.
- W2033996003 hasAuthorship W2033996003A5063080687 @default.
- W2033996003 hasAuthorship W2033996003A5079883757 @default.
- W2033996003 hasBestOaLocation W20339960031 @default.
- W2033996003 hasConcept C126322002 @default.
- W2033996003 hasConcept C141071460 @default.
- W2033996003 hasConcept C164705383 @default.
- W2033996003 hasConcept C2776741139 @default.
- W2033996003 hasConcept C2778105408 @default.
- W2033996003 hasConcept C3020341438 @default.
- W2033996003 hasConcept C42219234 @default.
- W2033996003 hasConcept C519063684 @default.
- W2033996003 hasConcept C71924100 @default.
- W2033996003 hasConceptScore W2033996003C126322002 @default.
- W2033996003 hasConceptScore W2033996003C141071460 @default.
- W2033996003 hasConceptScore W2033996003C164705383 @default.
- W2033996003 hasConceptScore W2033996003C2776741139 @default.
- W2033996003 hasConceptScore W2033996003C2778105408 @default.
- W2033996003 hasConceptScore W2033996003C3020341438 @default.
- W2033996003 hasConceptScore W2033996003C42219234 @default.
- W2033996003 hasConceptScore W2033996003C519063684 @default.
- W2033996003 hasConceptScore W2033996003C71924100 @default.
- W2033996003 hasIssue "1" @default.
- W2033996003 hasLocation W20339960031 @default.
- W2033996003 hasLocation W20339960032 @default.
- W2033996003 hasOpenAccess W2033996003 @default.
- W2033996003 hasPrimaryLocation W20339960031 @default.
- W2033996003 hasRelatedWork W1964324982 @default.
- W2033996003 hasRelatedWork W2012313463 @default.
- W2033996003 hasRelatedWork W2084731349 @default.
- W2033996003 hasRelatedWork W2324954285 @default.
- W2033996003 hasRelatedWork W2412721857 @default.
- W2033996003 hasRelatedWork W2413630130 @default.
- W2033996003 hasRelatedWork W2416599176 @default.
- W2033996003 hasRelatedWork W2417766826 @default.
- W2033996003 hasRelatedWork W3180187994 @default.
- W2033996003 hasRelatedWork W4240426186 @default.
- W2033996003 hasVolume "44" @default.
- W2033996003 isParatext "false" @default.
- W2033996003 isRetracted "false" @default.
- W2033996003 magId "2033996003" @default.
- W2033996003 workType "article" @default.